跳至主要内容
临床试验/NCT03613155
NCT03613155Unknown不适用

Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care

University Hospital, Toulouse1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2018年9月4日最近更新:
适应症

试验速览

阶段
不适用
入组人数
30
试验地点
1
主要终点
The state of anxiety of the patient assessed by Face Anxiety Scale

研究概览

简要总结

The emergency setting, frequently associated with pain and the feeling of loss of control, can cause anxiety in patients.

Reaction anxiety may be an appropriate response to an emergency; Nevertheless, attention must be paid to the evaluation and management of the latter especially as anxiety and pain are closely linked.

详细描述

There is a definite interest in the management of patients' pre-hospital anxiety. The literature reports a strong association between anxiety, post-traumatic stress and chronic pain. A study conducted at SAMU 31 also found that anxiety on arrival at the emergency department was a negative factor in the treatment of pain. Anxiety can reduce the pain threshold and promote hyperalgesia.

The management of patient anxiety in pre-hospital offers interesting results in terms of analgesia and satisfaction of users of care and should not be neglected.

MEOPA has recently been available in SMUR vehicles (emergency and resuscitation mobile service) at SAMU 31 (urgent medical assistance service); its availability can lead teams to change their practices. More and more emphasis is placed on the importance of positive communication and comfort for which MEOPA, with its conscious sedating effect, could be a facilitating factor.

The aim of our study is to evaluate the level of anxiety of patients treated by SMUR teams in Toulouse and receiving MEOPA following the usual indications for pain-induced pain or pain alleviation.

This is a pilot study, which focuses on the assessment of anxiety in patients treated in pre-hospital care by SMUR Toulouse and receiving MEOPA as part of their care. No data exists in the literature on this subject.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient over 18
  • Patient supported by a SMUR team from Toulouse
  • Patient receiving MEOPA during pre-hospital care (in the usual indications for pain relief or pain-induced care)
  • Patient having given his non-opposition to participate in the study

排除标准

  • Any patient with a contraindication to MEOPA:
  • Patient requiring pure oxygen ventilation
  • Intracranial hypertension
  • Any alteration of the state of consciousness preventing the patient's cooperation
  • Traumatic brain injury
  • Pneumothorax
  • Emphysema bubbles
  • Gas embolism
  • Diving accident
  • Abdominal gas distension
  • Patient who received an ophthalmic gas for ocular surgery less than three months old
  • Known and unsubstituted vitamin B12 deficiency
  • Patient under legal protection
  • Refusal of the patient to participate in the study
  • Barrier of the language or alteration of the communication
  • Patient in vital distress

结局指标

主要结局

The state of anxiety of the patient assessed by Face Anxiety Scale

时间窗: 2 hours

The state of anxiety of the patient assessed by FAS (face anxiety scale) self-assessment when supported by a SMUR team with MEOPA administration. The FAS, called the Anxiety Faces Scale, is a validated anxiety assessment scale that was originally developed in the context of Critical Care, Critical Care (ICU) management. The Faces Anxiety Scale is a valid single-item, self-report measure of state anxiety in intensive care patients that is easy to administer and imposes minimal respondent burden. It has the potential to be a useful instrument for the assessment of state anxiety by clinicians and for research into the reduction of anxiety in this vulnerable population.

次要结局

  • The pain felt by the patient, evaluated by the numerical scale (EN), in connection with his anxiety(2 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验